After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Teva- Pharmaceutical Industries Ltd. ADR is listed on the NYSE as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Teva- Pharmaceutical Industries Ltd. ADR is $30.84B. A total of 9.05 million shares were traded on the day, compared to an average of 11.12M shares.
In the most recent transaction, Bridger Management, LLC (1) bought 50,000 shares of TEVA for 24.99 per share on Nov 26 ’25. In a previous transaction on Nov 20 ’25, Fox Christine sold 28,229 shares at 24.78 per share. TEVA shares that EVP, Head of U.S. Commercial owns now total 63,647.
Among the insiders who bought shares, Fox Christine acquired of 28,229 shares on Nov 20 ’25 at a per-share price of $24.78. In another insider transaction, Fox Christine sold 30,000 shares at $25.11 per share on Nov 14 ’25. Company shares held by the EVP, Head of U.S. Commercial now total 28,384.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, TEVA has a high of $26.44 and a low of $12.47.
As of this writing, TEVA has an earnings estimate of $0.66 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of $0.78 per share and a lower estimate of $0.6. The company reported an EPS of $0.71 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TEVA’s latest balance sheet shows that the firm has $2.17B in Cash & Short Term Investments as of fiscal 2021. There were $23.46B in debt and $11.03B in liabilities at the time. Its Book Value Per Share was $6.32, while its Total Shareholder’s Equity was $11.24B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TEVA is Buy with a score of 4.80.
